Sutent
Links shared publicly online about this topic
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 23, 2011 at 5:19 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Yahoo health: Sutent Approved for Rare Pancreatic Cancer http://bit.ly/lrohqJ Full http://bit.ly/lP8e3J
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 24, 2011 at 12:49 am By:
Jennifer Ann Grisso Nurse and Active Health Library
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administratio... http://bit.ly/jHoEuw
Pfizer's Sutent... | Facebook
facebook.com — “The Farber Center for Radiation Oncology wrote: Pfizer's Sutent Drug Slows Pancreatic... Join Facebook to connect with The Farber Center for Radiation Oncology and others you may know.” View full resource at facebook.com
Most Recently Shared on January 22, 2010 at 6:30 pm By:
Dr. Leonard Farber Oncology and Physician Group
Pfizer's Sutent Drug Slows Pancreatic Cancer ..read more http://bit.ly/6rvHZj
FDA Approves Sutent for Pancreatic Cancer
onclive.com — “The FDA has approved Sutent (sunitinib) for the treatment of patients with unresectable, locally advanced, or metastatic pancreatic neuroendocrine tumors (pNET)” View full resource at onclive.com
Most Recently Shared on May 23, 2011 at 9:54 pm By:
The FDA has approved Sutent (sunitinib) for unresectable pancreatic neuroendocrine tumors (pNET) http://goo.gl/MnX17
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 7:16 am By:
FDA Approves Sutent for Rare Type of Pancreatic Cancer - http://bit.ly/j6v3Lp
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 8:13 am By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNew... http://bit.ly/lGiA67 #drug
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:06 am By:
MNT Drug Approvals Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3Wc7 #regulatory
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 7:06 am By:
MNT Pancreatic Can Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pancreaticcancer
Sutent for Rare Type of Pancreatic Cancer Approved by FDA
disabled-world.com — “Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body” View full resource at disabled-world.com
Most Recently Shared on May 22, 2011 at 9:21 pm By:
Disabled World Health Advocate and Health News
Sutent for Rare Type of Pancreatic Cancer Approved by FDA http://ff.im/-DWIfW
Sutent Gains Indication for Advanced Pancreatic Tumors - MPR
empr.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 2:35 pm By:
MPR News: Sutent Gains Indication for Advanced Pancreatic Tumors: The FDA has approved Sutent (sunitinib malate;... http://bit.ly/klWR8Y
Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
oncologynurseadvisor.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 23, 2011 at 2:50 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Sutent Gains Indication for Advanced Pancreatic Tumors http://goo.gl/fb/AhvBJ
US panel backs Pfizer's Sutent for pancreatic cancer | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel on Tuesday backed the use of Pfizer Inc's cancer drug Sutent to treat a rare type of pancreatic cancer that has very few treatment options.While” View full resource at reuters.com
Most Recently Shared on April 12, 2011 at 10:26 pm By:
US panel backs Pfizer's Sutent for pancreatic cancer http://reut.rs/fLElVg
US panel backs Pfizer's Sutent for pancreatic cancer | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel on Tuesday backed the use of Pfizer Inc's cancer drug Sutent to treat a rare type of pancreatic cancer that has very few treatment options.While” View full resource at reuters.com
Most Recently Shared on April 12, 2011 at 9:55 pm By:
US panel backs Pfizer's Sutent for pancreatic cancer http://bit.ly/eLHbVE
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors
medicalnewstoday.com — “The Pfizer drug Sutent® (sunitinib) has been approved for the treatment of advanced pancreatic neuroendocrine tumors by the U.S. Food and Drug Administration (FDA). Sutent® is the second t” View full resource at medicalnewstoday.com
Most Recently Shared on May 21, 2011 at 7:05 am By:
MNT Pancreatic Can Health News
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors http://mnt.to/3Wb8 #pancreaticcancer
US panel backs Pfizer's Sutent for pancreatic cancer | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel on Tuesday backed the use of Pfizer Inc's cancer drug Sutent to treat a rare type of pancreatic cancer that has very few treatment options.While” View full resource at reuters.com
Most Recently Shared on April 12, 2011 at 10:10 pm By:
US panel backs Pfizer's Sutent for pancreatic cancer: SILVER SPRING, Maryland (Reuters) - A U.S. a... http://bit.ly/edTNlh #health #news
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
allergydropz
Nashville's allergy experts. Allergycare of Cool Springs is pleased to offer a new, exciting and innovative allergy treatment that doesnt require shots!
-
Jennifer Ann Grisso
Jennifer, RN,BSN Business Minded RN, Over 20 years as an RN in most areas.Chicagoan !Great sense of humor. Learning and studying HIT. Sold Medical Supplies and Devices. Nursing experience in most areas, more in Cardiac.
-
Dr. Leonard Farber
The Farber Center for Radiation Oncology is a community based practice providing the latest radiation treatment techniques in a private practice setting
Advertisement
